Nω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast-Reference-Cited by-同舟云学术

Nω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast

Published:1991-07 Issue:1 Volume:200 Page:83-87
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Dundore Ronald L.,Pratt Phillip F.,O'Connor Bernard,Buchholz R.Allan,Pagani Edward D.

Publisher

Elsevier BV

Subject

Pharmacology

Reference14 articles.

1. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;Bradford;Anal. Biochem.,1976

2. Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats;Dundore;European J. Pharmacol.,1990

3. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries;Förstermann;Circ. Res.,1986

4. Regional haemodynamic changes during oral ingestion of NGmonoinethyl-L-arginine or NGnitro-L-arginine methyl ester in conscious Brattleboro rats;Gardiner;Br. J. Pharmacol.,1990

5. Phosphodiesterase enzyme inhibition and the potenliation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle;Harris;J. Pharmacol. Exp. Ther.,1989

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chaotic behavior of the coronary circulation;Medical & Biological Engineering & Computing;2008-04-02

2. Effect of zaprinast on nitric oxide levels in serum and aortic tissue;Methods and Findings in Experimental and Clinical Pharmacology;2004

3. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs;American Journal of Physiology-Heart and Circulatory Physiology;2001-03-01

4. Phosphodiesterase III and V Inhibitors on Pulmonary Artery from Pulmonary Hypertensive Rats: Differences Between Early and Established Pulmonary Hypertension;Journal of Cardiovascular Pharmacology;1998-08

5. Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5;European Journal of Pharmacology;1998-05